Tag: cell banking outsourcing market trends

Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.

#Cell Banking Outsourcing Market Size, Value And Growth Trajectory Through 2030#_x000D_

The cell banking outsourcing market has experienced rapid expansion in recent years. Its size is projected to increase from $12.86 billion in 2025 to $14.76 billion in 2026, achieving a compound annual growth rate (CAGR) of 14.8%. The historical growth of this market can be attributed to several factors, including the rise in biologics manufacturing, the increasing reliance on outsourced bioprocessing services, the expansion of vaccine production programs, the growing need for standardized cell line storage, and cost optimization initiatives by pharmaceutical companies._x000D_

_x000D_

The cell banking outsourcing market size is anticipated to undergo significant expansion over the next few years. It is forecast to grow to $24.12 billion in 2030, achieving a compound annual growth rate (CAGR) of 13.1%. The projected growth during this period is driven by a surge in cell and gene therapy pipelines, the rising demand for viral vector manufacturing, an increasing regulatory emphasis on cell line traceability, the development of personalized medicine, and the expansion of contract development and manufacturing organizations. Major trends expected in the forecast period include the increasing outsourcing of GMP-compliant cell banking services, a growing demand for multi-species cell banking capabilities, the standardization of cell line documentation and traceability, the broadening of viral and vector cell banking for advanced therapies, and an increasing preference for long-term cell bank storage agreements._x000D_

_x000D_

#Get A Free Sample Report With In-Depth Market Insights:#_x000D_

https://thebusinessresearchcompany.com/sample_request?id=79927291&type=smp&name=Cell%20Banking%20Outsourcing%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR_x000D_

_x000D_

#Cell Banking Outsourcing Market Demand Drivers: What’s Powering Industry Growth?#_x000D_

The increasing prevalence of chronic diseases is anticipated to drive the expansion of the cell banking outsourcing market in the future. These are enduring health conditions that manifest progressively and continue for prolonged durations, frequently necessitating continuous care. This growing burden of chronic illnesses stems from shifts in lifestyle, an aging demographic, and inherent genetic factors. The cell banking outsourcing market aids chronic disease research through the provision of specialized facilities, cutting-edge technologies, and skilled expertise, facilitating the effective storage, maintenance, and handling of cellular substances crucial for therapeutic advancements. For example, data from April 2025, provided by the NHS Confederation, a national association located in the UK, projects that by 2035, around 17% of the UK’s populace might be contending with at least four chronic conditions. Consequently, the escalating burden posed by chronic diseases is serving as a primary impetus for the expansion of the cell banking outsourcing market._x000D_

_x000D_

#Cell Banking Outsourcing Market Segment Performance And Emerging Opportunities#_x000D_

The cell banking outsourcing market covered in this report is segmented – _x000D_

_x000D_

1) By Type: Master Cell Banking, Working Cell Banking, Viral Cell Banking_x000D_

2) By Cell Type: Stem Cell Banking, Non-Stem Cell Banking_x000D_

3) By Phase: Bank Storage, Bank Characterization And Testing, Bank Preparation_x000D_

_x000D_

Subsegments:_x000D_

1) By Master Cell Banking: Human Master Cell Bank, Animal Master Cell Bank_x000D_

2) By Working Cell Banking: Human Working Cell Bank, Animal Working Cell Bank_x000D_

3) By Viral Cell Banking: Virus Bank For Vaccine Production, Viral Vector Bank For Gene Therapy, Adenovirus Bank_x000D_

_x000D_

#Cell Banking Outsourcing Market Innovation Trends: What Developments Are Reshaping The Industry?#_x000D_

Companies operating significantly within the cell banking outsourcing market are prioritizing the development of technologically advanced solutions, such as single-cell potency characterization platforms. This focus is intended to deliver more precise potency assessments and support the creation of high-quality cell therapies. A single-cell potency characterization platform functions as an advanced analytical system, designed to evaluate the functional capabilities and therapeutic potential of individual cells within varied cell populations. This provides deeper insights into cell behavior, potency, and their mechanisms of action, essential for research and clinical development. As an illustration, in January 2024, Cellply Srl, an Italy-based biotechnology company, launched VivaCyte. This end-to-end single-cell potency characterization platform integrates potency analysis with immunophenotyping, featuring fully automated operation, single-cell resolution, and rapid multi-parameter functional assessment, ultimately reducing development time, cost, and risk while enabling comprehensive evaluation of multiple cell therapy candidates across diverse process options._x000D_

_x000D_

#Cell Banking Outsourcing Market Key Players: Which Companies Lead Industry Competition?#_x000D_

Major companies operating in the cell banking outsourcing market are Lonza Group Ltd., WuXi AppTec, Charles River Laboratories, Labcorp Drug Development, Covance Inc., SGS Life Sciences, Sartorius AG, BioReliance, Cleancells, Clean Biologics, Texcell, Goodwin Biotechnology Inc., Perfectus Biomed Limited, BioStorage Technologies Inc., Toxikon Corp., PX’Therapeutics SA, Sigma-Aldrich Co. Ltd., Transcell Biolife Pvt Ltd, Eurofins Scientific SE, ViruSure GmbH _x000D_

_x000D_

#View The Full Cell Banking Outsourcing Market Report:#_x000D_

https://thebusinessresearchcompany.com/report/cell-banking-outsourcing-global-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR_x000D_

_x000D_

#Cell Banking Outsourcing Market Global Footprint: Which Region Leads The Market?#_x000D_

North America was the largest region in the cell banking outsourcing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell banking outsourcing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_

_x000D_

#Reach Out To Our Team:#_x000D_

_x000D_

The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_

Americas: +1 310-496-7795_x000D_

Asia: +44 7882 955267 & +91 8897263534_x000D_

Europe: +44 7882 955267_x000D_

Email us at: marketing@tbrc.info_x000D_

_x000D_

#Follow us on:#_x000D_

_x000D_

LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Through market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports provide more actionable and strategically valuable research.

Cell Banking Outsourcing Market Expansion Outlook: What Revenue Opportunities Lie Ahead?

The cell banking outsourcing market has experienced substantial growth over recent years. Projections indicate an increase from $12.86 billion in 2025 to $14.76 billion in 2026, reflecting a compound annual growth rate (CAGR) of 14.8%. This historic expansion has been driven by several key factors, including the advancement of biologics manufacturing, a growing dependence on outsourced bioprocessing solutions, the expansion of vaccine production initiatives, an escalating demand for standardized cell line storage, and cost optimization strategies implemented by pharmaceutical firms.

Over the coming years, the cell banking outsourcing market is anticipated to expand at a rapid pace, reaching $24.12 billion by 2030, with a compound annual growth rate (CAGR) of 13.1%. This forecasted growth is driven by a rise in cell and gene therapy pipelines, an increased need for viral vector manufacturing, heightened regulatory emphasis on cell line traceability, the progression of personalized medicine, and the broadening scope of contract development and manufacturing organizations. Key trends shaping the period ahead include a greater shift toward outsourcing GMP-compliant cell banking services, a growing demand for capabilities in multi-species cell banking, the standardization of documentation and traceability for cell lines, the expansion of viral and vector cell banking tailored to advanced therapies, and an increasing preference for long-term storage agreements for cell banks.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15754&type=smp&utm_source=BlogsPR&utm_medium=Paid&utm_campaign=Jul_PR

Cell Banking Outsourcing Market Expansion Drivers: What Is Shaping Future Growth?

The anticipated increase in chronic disease prevalence is set to drive expansion within the cell banking outsourcing market moving forward. Chronic diseases are defined as long-term medical conditions that emerge gradually and continue over prolonged periods, frequently demanding sustained care. Factors such as lifestyle modifications, aging demographics, and hereditary susceptibilities are fueling this growing burden. By offering specialized infrastructure, cutting-edge technologies, and expert proficiency for the efficient storage, preservation, and processing of cellular materials essential to therapeutic development, the cell banking outsourcing sector aids chronic disease research. In April 2025, the NHS Confederation, a UK-based national body, projected that by 2035, approximately 17% of the United Kingdom’s population might be managing four or more chronic conditions. Consequently, the escalating prevalence of chronic diseases is fueling the growth of the cell banking outsourcing market.

Cell Banking Outsourcing Market Segment Analysis Highlighting Growth Areas

The cell banking outsourcing market covered in this report is segmented –

1) By Type: Master Cell Banking, Working Cell Banking, Viral Cell Banking

2) By Cell Type: Stem Cell Banking, Non-Stem Cell Banking

3) By Phase: Bank Storage, Bank Characterization And Testing, Bank Preparation

Subsegments:

1) By Master Cell Banking: Human Master Cell Bank, Animal Master Cell Bank

2) By Working Cell Banking: Human Working Cell Bank, Animal Working Cell Bank

3) By Viral Cell Banking: Virus Bank For Vaccine Production, Viral Vector Bank For Gene Therapy, Adenovirus Bank

Cell Banking Outsourcing Market Strategic Trends: What Is Defining The Next Phase Of Growth?

Leading firms in the cell banking outsourcing space are prioritizing the creation of cutting-edge solutions, including single-cell potency characterization platforms, to offer more accurate potency measurements and aid in the production of superior cell therapies. This type of platform is an advanced analytical tool that assesses the functional performance and therapeutic promise of individual cells within mixed populations, providing detailed understanding of cell dynamics, efficacy, and mode of action for both research and clinical uses. As an example, in January 2024, Cellply Srl, a biotechnology company headquartered in Italy, unveiled VivaCyte, a complete single-cell potency characterization system that merges potency evaluation with immunophenotyping, offering fully automated workflows, single-cell detail, and swift multiparameter functional testing to shorten development timelines, cut expenses, and lower risk, while allowing thorough screening of various cell therapy products across different procedures.

Cell Banking Outsourcing Market Leading Companies: Who Holds Significant Market Presence?

Major companies operating in the cell banking outsourcing market are Lonza Group Ltd., WuXi AppTec, Charles River Laboratories, Labcorp Drug Development, Covance Inc., SGS Life Sciences, Sartorius AG, BioReliance, Cleancells, Clean Biologics, Texcell, Goodwin Biotechnology Inc., Perfectus Biomed Limited, BioStorage Technologies Inc., Toxikon Corp., PX’Therapeutics SA, Sigma-Aldrich Co. Ltd., Transcell Biolife Pvt Ltd, Eurofins Scientific SE, ViruSure GmbH

Access The Complete Cell Banking Outsourcing Market Report:

https://www.thebusinessresearchcompany.com/report/cell-banking-outsourcing-global-market-report?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=Jul_PR

Cell Banking Outsourcing Market Regional Outlook: Where Are The Largest Opportunities Located?

North America was the largest region in the cell banking outsourcing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell banking outsourcing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=home_page_test

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

How Will The Market Value Of The Cell Banking Outsourcing Market Increase Between 2026 And 2030?

The cell banking outsourcing market has experienced substantial growth in recent years. Its value is expected to increase from $12.86 billion in 2025 to $14.76 billion in 2026, with a compound annual growth rate (CAGR) of 14.8%. This historic expansion can be attributed to factors such as the rise in biologics manufacturing, a growing reliance on outsourced bioprocessing services, the development of vaccine production programs, an increased requirement for standardized cell line storage, and cost optimization strategies employed by pharmaceutical companies.

Projections indicate significant expansion for the cell banking outsourcing market in the coming years. This sector is anticipated to reach a valuation of $24.12 billion in 2030, exhibiting a robust compound annual growth rate (CAGR) of 13.1%. Several factors are contributing to this forecasted expansion, including a significant increase in cell and gene therapy development pipelines, a heightened need for viral vector production, a greater emphasis from regulators on ensuring cell line traceability, the progression of personalized medicine, and the proliferation of contract development and manufacturing organizations. Key trends defining this period involve an uptick in outsourcing for GMP-compliant cell banking, a growing requirement for multi-species cell banking capacities, efforts to standardize cell line documentation and traceability, the broadening scope of viral and vector cell banking for advanced therapeutic applications, and a stronger inclination towards extended cell bank storage contracts.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15754&type=smp

Which Growth Factors Are Strengthening The Cell Banking Outsourcing Market Landscape?

The cell banking outsourcing market is projected to expand due to the escalating prevalence of chronic diseases. These are enduring health conditions that manifest slowly and endure for lengthy durations, frequently necessitating continuous care. The growing impact of chronic diseases stems from evolving lifestyles, an aging global demographic, and inherited genetic factors. In its role, the cell banking outsourcing market aids chronic disease research through the provision of dedicated facilities, cutting-edge technologies, and skilled expertise, facilitating the effective storage, maintenance, and handling of cellular materials crucial for therapeutic advancements. For example, the NHS Confederation, a UK-based national association, reported in April 2025 that projections indicate 17% of the UK population might be afflicted with four or more chronic conditions by 2035. Consequently, the expanding burden of chronic illnesses is a primary catalyst for the growth of the cell banking outsourcing market.

What Segment Categories Are Evaluated In The Cell Banking Outsourcing Market Study?

The cell banking outsourcing market covered in this report is segmented –

1) By Type: Master Cell Banking, Working Cell Banking, Viral Cell Banking

2) By Cell Type: Stem Cell Banking, Non-Stem Cell Banking

3) By Phase: Bank Storage, Bank Characterization And Testing, Bank Preparation

Subsegments:

1) By Master Cell Banking: Human Master Cell Bank, Animal Master Cell Bank

2) By Working Cell Banking: Human Working Cell Bank, Animal Working Cell Bank

3) By Viral Cell Banking: Virus Bank For Vaccine Production, Viral Vector Bank For Gene Therapy, Adenovirus Bank

What Trends Are Driving Changes In The Cell Banking Outsourcing Market?

Companies operating in the cell banking outsourcing market are prioritizing the development of sophisticated solutions, including single-cell potency characterization platforms. These platforms aim to deliver more precise potency assessments and support the creation of high-quality cell therapies. A single-cell potency characterization platform is defined as an advanced analytical system engineered to assess the functional capabilities and therapeutic potential of individual cells within heterogeneous cell populations, thereby offering enhanced insight into cell behavior, potency, and mechanism of action for both research and clinical development. Illustrating this trend, in January 2024, Cellply Srl, an Italy-based biotechnology company, unveiled VivaCyte. This comprehensive single-cell potency characterization platform integrates potency analysis with immunophenotyping, features fully automated operation, single-cell resolution, and rapid multi-parameter functional assessment, all designed to mitigate development time, cost, and risk while enabling an exhaustive evaluation of multiple cell therapy candidates across diverse process options.

Who Are The Businesses Driving Activity In The Cell Banking Outsourcing Market?

Major companies operating in the cell banking outsourcing market are Lonza Group Ltd., WuXi AppTec, Charles River Laboratories, Labcorp Drug Development, Covance Inc., SGS Life Sciences, Sartorius AG, BioReliance, Cleancells, Clean Biologics, Texcell, Goodwin Biotechnology Inc., Perfectus Biomed Limited, BioStorage Technologies Inc., Toxikon Corp., PX’Therapeutics SA, Sigma-Aldrich Co. Ltd., Transcell Biolife Pvt Ltd, Eurofins Scientific SE, ViruSure GmbH

Access The Complete Cell Banking Outsourcing Market Report:

https://www.thebusinessresearchcompany.com/report/cell-banking-outsourcing-global-market-report

Which Region Is The Primary Market For The Cell Banking Outsourcing Market?

North America was the largest region in the cell banking outsourcing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell banking outsourcing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Cell Banking Outsourcing Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/sample.aspx?id=15754&type=smp

Browse Through More Reports Similar to the Global Cell Banking Outsourcing Market 2026, By The Business Research Company

Cell Banking Outsourcing Market Report 2026

https://www.thebusinessresearchcompany.com/report/cell-banking-outsourcing-global-market-report

Hospital Outsourcing Market Report 2026

https://www.thebusinessresearchcompany.com/report/hospital-outsourcing-global-market-report

Call Center Outsourcing Market Report 2026

https://www.thebusinessresearchcompany.com/report/call-center-outsourcing-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Are The Market Size Estimates For The Cell Banking Outsourcing Market In 2026 And 2030?

The cell banking outsourcing market size has seen rapid growth in recent years. This market is set to expand from $12.86 billion in 2025 to $14.76 billion in 2026, achieving a compound annual growth rate (CAGR) of 14.8%. The historical growth can be attributed to several factors including the growth in biologics manufacturing, increasing reliance on outsourced bioprocessing services, expansion of vaccine production programs, rising need for standardized cell line storage, and cost optimization by pharmaceutical companies.

The cell banking outsourcing market is projected to experience substantial expansion in the coming years. This market is anticipated to reach a valuation of $24.12 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 13.1%. This expansion during the projection period is driven by several factors, including a surge in cell and gene therapy pipelines, increasing demand for viral vector manufacturing, stricter regulatory scrutiny on cell line traceability, advancements in personalized medicine development, and the growth of contract development and manufacturing organizations. Key trends anticipated during the forecast period encompass the increasing outsourcing of GMP-compliant cell banking services, a growing need for multi-species cell banking capabilities, efforts to standardize cell line documentation and traceability, the expansion of viral and vector cell banking for advanced therapies, and a rising inclination towards long-term cell bank storage agreements.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15754&type=smp

Which Factors Are Influencing The Growth Of The Cell Banking Outsourcing Market?

The cell banking outsourcing market is projected to expand significantly due to the increasing burden of chronic diseases. These are long-lasting medical conditions that develop gradually and persist over extended periods, often requiring ongoing management. Lifestyle changes, aging populations, and genetic predispositions are driving the increasing prevalence of chronic diseases. The cell banking outsourcing market supports chronic disease research by providing specialized infrastructure, advanced technologies, and expert capabilities essential for the efficient storage, preservation, and processing of cellular materials used in therapeutic development. For instance, in April 2025, according to the NHS Confederation, a UK-based national association, it is estimated that by 2035, 17% of the UK population could be living with four or more chronic conditions. Therefore, the rise in the burden of chronic diseases is a key factor driving the growth of the cell banking outsourcing market.

What Are The Different Segment Types In The Cell Banking Outsourcing Market Segment Breakdown?

The cell banking outsourcing market covered in this report is segmented –

1) By Type: Master Cell Banking, Working Cell Banking, Viral Cell Banking

2) By Cell Type: Stem Cell Banking, Non-Stem Cell Banking

3) By Phase: Bank Storage, Bank Characterization And Testing, Bank Preparation

Subsegments:

1) By Master Cell Banking: Human Master Cell Bank, Animal Master Cell Bank

2) By Working Cell Banking: Human Working Cell Bank, Animal Working Cell Bank

3) By Viral Cell Banking: Virus Bank For Vaccine Production, Viral Vector Bank For Gene Therapy, Adenovirus Bank

Which Trends Are Contributing To Changes In The Cell Banking Outsourcing Market?

Major companies active in the cell banking outsourcing market are prioritizing the development of technologically advanced solutions, including single-cell potency characterization platforms, to provide more precise potency assessments and support the creation of high-quality cell therapies. A single-cell potency characterization platform refers to a sophisticated analytical system designed to evaluate the functional capabilities and therapeutic potential of individual cells within heterogeneous cell populations, thereby offering deeper insights into cell behavior, potency, and mechanisms of action for research and clinical development. For example, in January 2024, Cellply Srl, an Italy-based biotechnology company, launched VivaCyte, an all-encompassing single-cell potency characterization platform that integrates potency analysis with immunophenotyping. This platform features fully automated operation, single-cell resolution, and rapid multi-parameter functional assessment, aiming to reduce development time, cost, and risk while enabling comprehensive evaluation of numerous cell therapy candidates across diverse process options.

Who Are The Well-Known Companies In The Cell Banking Outsourcing Market?

Major companies operating in the cell banking outsourcing market are Lonza Group Ltd., WuXi AppTec, Charles River Laboratories, Labcorp Drug Development, Covance Inc., SGS Life Sciences, Sartorius AG, BioReliance, Cleancells, Clean Biologics, Texcell, Goodwin Biotechnology Inc., Perfectus Biomed Limited, BioStorage Technologies Inc., Toxikon Corp., PX’Therapeutics SA, Sigma-Aldrich Co. Ltd., Transcell Biolife Pvt Ltd, Eurofins Scientific SE, ViruSure GmbH

Get The Full Cell Banking Outsourcing Market Report:

https://www.thebusinessresearchcompany.com/report/cell-banking-outsourcing-global-market-report

Which Region Is The Top Contributor To The Cell Banking Outsourcing Market By Share?

North America was the largest region in the cell banking outsourcing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell banking outsourcing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Cell Banking Outsourcing Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/cell-banking-outsourcing-global-market-report

Browse Through More Reports Similar to the Global Cell Banking Outsourcing Market 2026, By The Business Research Company

Cell Banking Outsourcing Market Report 2026

https://www.thebusinessresearchcompany.com/report/cell-banking-outsourcing-global-market-report

Hospital Outsourcing Market Report 2026

https://www.thebusinessresearchcompany.com/report/hospital-outsourcing-global-market-report

Call Center Outsourcing Market Report 2026

https://www.thebusinessresearchcompany.com/report/call-center-outsourcing-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

How Large Is The Cell Banking Outsourcing Market Projected To Become By 2030 Based On Its 2026 Valuation?

The cell banking outsourcing market’s size has witnessed rapid expansion in recent years. This market is expected to grow from $12.86 billion in 2025 to $14.76 billion in 2026, achieving a compound annual growth rate (CAGR) of 14.8%. The growth recorded during the historic period can be attributed to factors such as the increase in biologics manufacturing, a growing reliance on outsourced bioprocessing services, the expansion of vaccine production programs, a heightened need for standardized cell line storage, and cost optimization initiatives by pharmaceutical companies.

The market for outsourced cell banking services is projected to experience substantial expansion in the coming years. This market is anticipated to reach $24.12 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 13.1%. Several factors contribute to this projected increase, including a proliferation of cell and gene therapy developments, a heightened need for viral vector production, enhanced regulatory scrutiny on cell line tracking, advancements in personalized medicine, and the growth of contract development and manufacturing organizations. Key trends anticipated during this period encompass a greater reliance on outsourcing for GMP-compliant cell banking, an escalating need for multi-species cell banking functionalities, the establishment of standardized cell line documentation and traceability protocols, an increase in viral and vector cell banking for advanced therapeutic applications, and a rising inclination towards long-term storage agreements for cell banks.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15754&type=smp

Which Market Drivers Are Supporting The Expansion Of The Cell Banking Outsourcing Market?

The increasing burden of chronic diseases is projected to stimulate the expansion of the cell banking outsourcing market in the future. Chronic diseases are defined as persistent medical conditions that develop gradually and last for extended periods, often requiring ongoing management. This escalating burden of chronic diseases is attributed to lifestyle modifications, aging populations, and genetic predispositions. The cell banking outsourcing market supports research into chronic diseases by providing specialized infrastructure, advanced technologies, and expert capabilities, which facilitate the efficient storage, preservation, and processing of cellular materials essential for therapeutic development. For instance, in April 2025, the NHS Confederation, a UK-based national association, estimated that by 2035, 17% of the UK population could be living with four or more chronic conditions. Therefore, the rising burden of chronic diseases is a primary driver for the growth of the cell banking outsourcing market.

What Segment Groups Are Identified Within The Cell Banking Outsourcing Market?

The cell banking outsourcing market covered in this report is segmented –

1) By Type: Master Cell Banking, Working Cell Banking, Viral Cell Banking

2) By Cell Type: Stem Cell Banking, Non-Stem Cell Banking

3) By Phase: Bank Storage, Bank Characterization And Testing, Bank Preparation

Subsegments:

1) By Master Cell Banking: Human Master Cell Bank, Animal Master Cell Bank

2) By Working Cell Banking: Human Working Cell Bank, Animal Working Cell Bank

3) By Viral Cell Banking: Virus Bank For Vaccine Production, Viral Vector Bank For Gene Therapy, Adenovirus Bank

What Trends Are Advancing Progress In The Cell Banking Outsourcing Market?

Major companies operating in the cell banking outsourcing market are concentrating on creating technologically advanced solutions, such as single-cell potency characterization platforms, to deliver more precise potency assessments and support the development of high-quality cell therapies. A single-cell potency characterization platform refers to an advanced analytical system designed to evaluate the functional capabilities and therapeutic potential of individual cells within heterogeneous cell populations, enabling deeper insight into cell behavior, potency, and mechanism of action for research and clinical development. For instance, in January 2024, Cellply Srl, an Italy-based biotechnology company, launched VivaCyte, an end-to-end single-cell potency characterization platform that integrates potency analysis with immunophenotyping, featuring fully automated operation, single-cell resolution, and rapid multi-parameter functional assessment to reduce development time, cost, and risk while enabling comprehensive evaluation of multiple cell therapy candidates across diverse process options.

Which Companies Hold Significant Positions In The Cell Banking Outsourcing Market?

Major companies operating in the cell banking outsourcing market are Lonza Group Ltd., WuXi AppTec, Charles River Laboratories, Labcorp Drug Development, Covance Inc., SGS Life Sciences, Sartorius AG, BioReliance, Cleancells, Clean Biologics, Texcell, Goodwin Biotechnology Inc., Perfectus Biomed Limited, BioStorage Technologies Inc., Toxikon Corp., PX’Therapeutics SA, Sigma-Aldrich Co. Ltd., Transcell Biolife Pvt Ltd, Eurofins Scientific SE, ViruSure GmbH

Read the full cell banking outsourcing market report here:

https://www.thebusinessresearchcompany.com/report/cell-banking-outsourcing-global-market-report

How Is The Cell Banking Outsourcing Market Distributed Across Key Geographic Regions?

North America was the largest region in the cell banking outsourcing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell banking outsourcing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Cell Banking Outsourcing Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=15754&type=smp

Browse Through More Reports Similar to the Global Cell Banking Outsourcing Market 2026, By The Business Research Company

Cell Banking Outsourcing Market Report 2026

https://www.thebusinessresearchcompany.com/report/cell-banking-outsourcing-global-market-report

Hospital Outsourcing Market Report 2026

https://www.thebusinessresearchcompany.com/report/hospital-outsourcing-global-market-report

Call Center Outsourcing Market Report 2026

https://www.thebusinessresearchcompany.com/report/call-center-outsourcing-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

How Large Is The Cell Banking Outsourcing Market Projected To Become By 2030 Based On Its 2026 Valuation?

The cell banking outsourcing market’s size has witnessed rapid expansion in recent years. This market is expected to grow from $12.86 billion in 2025 to $14.76 billion in 2026, achieving a compound annual growth rate (CAGR) of 14.8%. The growth recorded during the historic period can be attributed to factors such as the increase in biologics manufacturing, a growing reliance on outsourced bioprocessing services, the expansion of vaccine production programs, a heightened need for standardized cell line storage, and cost optimization initiatives by pharmaceutical companies.

The market for outsourced cell banking services is projected to experience substantial expansion in the coming years. This market is anticipated to reach $24.12 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 13.1%. Several factors contribute to this projected increase, including a proliferation of cell and gene therapy developments, a heightened need for viral vector production, enhanced regulatory scrutiny on cell line tracking, advancements in personalized medicine, and the growth of contract development and manufacturing organizations. Key trends anticipated during this period encompass a greater reliance on outsourcing for GMP-compliant cell banking, an escalating need for multi-species cell banking functionalities, the establishment of standardized cell line documentation and traceability protocols, an increase in viral and vector cell banking for advanced therapeutic applications, and a rising inclination towards long-term storage agreements for cell banks.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15754&type=smp

Which Market Drivers Are Supporting The Expansion Of The Cell Banking Outsourcing Market?

The increasing burden of chronic diseases is projected to stimulate the expansion of the cell banking outsourcing market in the future. Chronic diseases are defined as persistent medical conditions that develop gradually and last for extended periods, often requiring ongoing management. This escalating burden of chronic diseases is attributed to lifestyle modifications, aging populations, and genetic predispositions. The cell banking outsourcing market supports research into chronic diseases by providing specialized infrastructure, advanced technologies, and expert capabilities, which facilitate the efficient storage, preservation, and processing of cellular materials essential for therapeutic development. For instance, in April 2025, the NHS Confederation, a UK-based national association, estimated that by 2035, 17% of the UK population could be living with four or more chronic conditions. Therefore, the rising burden of chronic diseases is a primary driver for the growth of the cell banking outsourcing market.

What Segment Groups Are Identified Within The Cell Banking Outsourcing Market?

The cell banking outsourcing market covered in this report is segmented –

1) By Type: Master Cell Banking, Working Cell Banking, Viral Cell Banking

2) By Cell Type: Stem Cell Banking, Non-Stem Cell Banking

3) By Phase: Bank Storage, Bank Characterization And Testing, Bank Preparation

Subsegments:

1) By Master Cell Banking: Human Master Cell Bank, Animal Master Cell Bank

2) By Working Cell Banking: Human Working Cell Bank, Animal Working Cell Bank

3) By Viral Cell Banking: Virus Bank For Vaccine Production, Viral Vector Bank For Gene Therapy, Adenovirus Bank

What Trends Are Advancing Progress In The Cell Banking Outsourcing Market?

Major companies operating in the cell banking outsourcing market are concentrating on creating technologically advanced solutions, such as single-cell potency characterization platforms, to deliver more precise potency assessments and support the development of high-quality cell therapies. A single-cell potency characterization platform refers to an advanced analytical system designed to evaluate the functional capabilities and therapeutic potential of individual cells within heterogeneous cell populations, enabling deeper insight into cell behavior, potency, and mechanism of action for research and clinical development. For instance, in January 2024, Cellply Srl, an Italy-based biotechnology company, launched VivaCyte, an end-to-end single-cell potency characterization platform that integrates potency analysis with immunophenotyping, featuring fully automated operation, single-cell resolution, and rapid multi-parameter functional assessment to reduce development time, cost, and risk while enabling comprehensive evaluation of multiple cell therapy candidates across diverse process options.

Which Companies Hold Significant Positions In The Cell Banking Outsourcing Market?

Major companies operating in the cell banking outsourcing market are Lonza Group Ltd., WuXi AppTec, Charles River Laboratories, Labcorp Drug Development, Covance Inc., SGS Life Sciences, Sartorius AG, BioReliance, Cleancells, Clean Biologics, Texcell, Goodwin Biotechnology Inc., Perfectus Biomed Limited, BioStorage Technologies Inc., Toxikon Corp., PX’Therapeutics SA, Sigma-Aldrich Co. Ltd., Transcell Biolife Pvt Ltd, Eurofins Scientific SE, ViruSure GmbH

Read the full cell banking outsourcing market report here:

https://www.thebusinessresearchcompany.com/report/cell-banking-outsourcing-global-market-report

How Is The Cell Banking Outsourcing Market Distributed Across Key Geographic Regions?

North America was the largest region in the cell banking outsourcing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell banking outsourcing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Cell Banking Outsourcing Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=15754&type=smp

Browse Through More Reports Similar to the Global Cell Banking Outsourcing Market 2026, By The Business Research Company

Cell Banking Outsourcing Market Report 2026

https://www.thebusinessresearchcompany.com/report/cell-banking-outsourcing-global-market-report

Hospital Outsourcing Market Report 2026

https://www.thebusinessresearchcompany.com/report/hospital-outsourcing-global-market-report

Call Center Outsourcing Market Report 2026

https://www.thebusinessresearchcompany.com/report/call-center-outsourcing-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Uncover key drivers, emerging technologies, and competitive movements shaping the cell banking outsourcing market from 2026–2035 with trusted insights from The Business Research Company

What upper market value could the Cell Banking Outsourcing Market reach by 2030 starting from 2026 levels?

The cell banking outsourcing market has seen rapid expansion in recent years. It is projected to grow from $12.86 billion in 2025 to $14.76 billion in 2026, achieving a compound annual growth rate (CAGR) of 14.8%. This historical growth is largely due to the increase in biologics manufacturing, a greater dependence on outsourced bioprocessing services, the expansion of vaccine production programs, the rising requirement for standardized cell line storage, and cost optimization initiatives by pharmaceutical companies.

The cell banking outsourcing market is projected for significant expansion in the coming years, with its size anticipated to reach $24.12 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 13.1%. This projected growth over the forecast period stems from several factors, including a surge in cell and gene therapy pipelines, an escalating demand for viral vector manufacturing, a heightened regulatory focus on cell line traceability, the progression of personalized medicine development, and the broadening reach of contract development and manufacturing organizations. Key developments expected during this period involve the increasing outsourcing of gmp-compliant cell banking services, a growing need for multi-species cell banking capabilities, the establishment of standardized cell line documentation and traceability, the expansion of viral and vector cell banking specifically for advanced therapies, and a rising inclination towards long-term cell bank storage agreements.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15754&type=smp

Which Drivers Are Influencing Long-Term Growth In The Cell Banking Outsourcing Market?

The escalating prevalence of chronic illnesses is anticipated to fuel the expansion of the cell banking outsourcing market in the future. These are enduring health conditions that manifest slowly and continue for prolonged durations, frequently necessitating continuous care. The growing weight of chronic diseases stems from alterations in lifestyle, demographic shifts towards older populations, and inherent genetic factors. This market aids chronic disease research through the provision of specialized facilities, cutting-edge technologies, and skilled expertise, facilitating the effective storage, maintenance, and handling of cellular substances crucial for developing therapies. As an illustration, in April 2025, the NHS Confederation, a national association located in the UK, reported an estimation that by 2035, 17% of the UK population might experience four or more chronic conditions. Consequently, the increased burden of chronic diseases is serving as a catalyst for the expansion of the cell banking outsourcing market.

Which Segments Are Driving Activity In The Cell Banking Outsourcing Market?

The cell banking outsourcing market covered in this report is segmented –

1) By Type: Master Cell Banking, Working Cell Banking, Viral Cell Banking

2) By Cell Type: Stem Cell Banking, Non-Stem Cell Banking

3) By Phase: Bank Storage, Bank Characterization And Testing, Bank Preparation

Subsegments:

1) By Master Cell Banking: Human Master Cell Bank, Animal Master Cell Bank

2) By Working Cell Banking: Human Working Cell Bank, Animal Working Cell Bank

3) By Viral Cell Banking: Virus Bank For Vaccine Production, Viral Vector Bank For Gene Therapy, Adenovirus Bank

Which Competitive Trends Are Impacting The Structure Of The Cell Banking Outsourcing Market?

Leading companies in the cell banking outsourcing market are concentrating on developing technologically advanced solutions, such as single-cell potency characterization platforms, to deliver more precise potency assessments and support the creation of high-quality cell therapies. A single-cell potency characterization platform refers to an advanced analytical system designed to evaluate the functional capabilities and therapeutic potential of individual cells within heterogeneous cell populations, thereby enabling deeper insight into cell behavior, potency, and mechanism of action for research and clinical development. For instance, in January 2024, Cellply Srl, an Italy-based biotechnology company, launched VivaCyte, an end-to-end single-cell potency characterization platform that integrates potency analysis with immunophenotyping, featuring fully automated operation, single-cell resolution, and rapid multi-parameter functional assessment. This aims to reduce development time, cost, and risk while enabling comprehensive evaluation of multiple cell therapy candidates across diverse process options.

Which Key Market Players Are Investing In Expansion And Innovation Within The Cell Banking Outsourcing Market?

Major companies operating in the cell banking outsourcing market are Lonza Group Ltd., WuXi AppTec, Charles River Laboratories, Labcorp Drug Development, Covance Inc., SGS Life Sciences, Sartorius AG, BioReliance, Cleancells, Clean Biologics, Texcell, Goodwin Biotechnology Inc., Perfectus Biomed Limited, BioStorage Technologies Inc., Toxikon Corp., PX’Therapeutics SA, Sigma-Aldrich Co. Ltd., Transcell Biolife Pvt Ltd, Eurofins Scientific SE, ViruSure GmbH

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/cell-banking-outsourcing-global-market-report

Which Regions Are Poised For Strategic Growth In The Cell Banking Outsourcing Market?

North America was the largest region in the cell banking outsourcing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell banking outsourcing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Cell Banking Outsourcing Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=15754&type=smp

Browse Through More Reports Similar to the Global Cell Banking Outsourcing Market 2026, By The Business Research Company

Cell Banking Outsourcing Market Report 2026

https://www.thebusinessresearchcompany.com/report/cell-banking-outsourcing-global-market-report

Hospital Outsourcing Market Report 2026

https://www.thebusinessresearchcompany.com/report/hospital-outsourcing-global-market-report

Call Center Outsourcing Market Report 2026

https://www.thebusinessresearchcompany.com/report/call-center-outsourcing-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Uncover key drivers, emerging technologies, and competitive movements shaping the otc drug and dietary supplement market from 2025–2034 with trusted insights from The Business Research Company

What Is The Predicted Size Of The OTC Drug And Dietary Supplement Industry By 2029?

The cell banking outsourcing market has demonstrated rapid expansion in recent years. This market is expected to surge from $11.19 billion in 2024 to $12.86 billion in 2025, propelled by a compound annual growth rate (CAGR) of 15.0%. Historically, this growth has been fueled by an increase in the prevalence of chronic diseases, a rise in government initiatives, supportive regulatory frameworks and guidelines, and the proliferation of banking services.

The cell banking outsourcing market is poised for substantial expansion in the coming years. This market is projected to reach $21.65 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 13.9%. Several factors are expected to fuel this growth during the forecast period, including the increasing adoption of cellular products, a surging demand for monoclonal antibodies, the expanding use of stem cell therapies, a rising geriatric population, and a growing reliance on cell-based treatments. Noteworthy trends anticipated in this period encompass product innovations, technological advancements, increased investments in research and development, and strategic collaborations between biotech companies and specialized cell banking services.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15754&type=smp

What Major Drivers Are Impacting The OTC Drug And Dietary Supplement Market?

The increasing prevalence of chronic illnesses is anticipated to drive the expansion of the cell banking outsourcing market in the future. These conditions are characterized by their protracted nature, usually emerging slowly and enduring for a considerable duration. The growing occurrence of chronic diseases stems from multiple contributing elements, such as evolving lifestyles, an aging demographic, and inherited susceptibilities. Outsourcing cell banking services is crucial for advancing research and development endeavors focused on tackling chronic illnesses, offering specialized knowledge, necessary resources, and facilities not typically found internally. As an illustration, data from July 2023, sourced from the Department of the Treasury – Australia’s national treasury and financial department – indicated that during 2020–21, almost half of the Australian population across all age groups (46.6%) suffered from at least one chronic disease, while nearly one in five (18.6%) experienced two or more chronic conditions. Consequently, the escalating burden of chronic diseases is fueling the expansion of the cell banking outsourcing market.

Which Segment Categories Are Driving Maximum Growth In The OTC Drug And Dietary Supplement Market?

The cell banking outsourcing market covered in this report is segmented –

1) By Type: Master Cell Banking, Working Cell Banking, Viral Cell Banking

2) By Cell Type: Stem Cell Banking, Non-Stem Cell Banking

3) By Phase: Bank Storage, Bank Characterization And Testing, Bank Preparation

Subsegments:

1) By Master Cell Banking: Human Master Cell Bank, Animal Master Cell Bank

2) By Working Cell Banking: Human Working Cell Bank, Animal Working Cell Bank

3) By Viral Cell Banking: Virus Bank For Vaccine Production, Viral Vector Bank For Gene Therapy, Adenovirus Bank

Which Long-Term Trends Will Play A Crucial Role In The OTC Drug And Dietary Supplement Market?

Leading companies active in the cell banking outsourcing market are concentrating on developing technologically advanced solutions, such as single-cell potency characterization platforms, to provide precise and detailed analysis of individual cell potency. A single-cell potency characterization platform is a sophisticated technology or a set of methodologies designed to assess and measure the potency and functional capabilities of individual cells within a cell population. For instance, in January 2024, Cellply Srl, an Italy-based biotechnology company, introduced VivaCyte, its flagship product. This end-to-end single-cell potency characterization platform integrates potency analysis and immunophenotyping to streamline cell therapy research and development. VivaCyte operates as a fully automated, standalone platform with single-cell resolution, engineered to reduce development times, costs, and risks by rapidly and comprehensively characterizing the complex functionality and mechanism of action of potential cellular immunotherapies. This platform allows for the rapid testing of multiple cell therapy candidates from various process options against multiple target tumor cells, delivering reproducible immune cell characterization and single-cell functional characterization in a fraction of the time required by existing analytical tools.

Who Are The Dominant Players In The OTC Drug And Dietary Supplement Market Today?

Major companies operating in the cell banking outsourcing market are LabCorp Drug Development, SGS Life Sciences, Lonza Group Ltd., WuXi AppTec, Charles River Laboratories, Sigma-Aldrich Co. Ltd., Covance Inc., Global Stem Inc., LifeCell, Cryoviva India, Sartorius AG, Bio Reliance, CordLife, Reliance Life Sciences, Cryo-Cell International Inc., Toxikon Corp., Cleancells, Clean Biologics, Texcell, PX’Therapeutics SA, Goodwin Biotechnology Inc., Transcell Biolife Pvt Ltd., Perfectus Biomed Limited, BioStorage Technologies Inc.

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/cell-banking-outsourcing-global-market-report

Which Region Is At The Forefront Of Innovation In The OTC Drug And Dietary Supplement Market?

North America was the largest region in the cell banking outsourcing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell banking outsourcing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=15754&type=smp

Browse Through More Reports Similar to the Global OTC Drug And Dietary Supplement Market 2025, By The Business Research Company

Cell Counting Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cell-counting-global-market-report

Cellulose Esters And Ethers Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cellulose-esters-and-ethers-global-market-report

Fuel Cell Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/fuel-cell-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim 20% Off Global Market Reports With Code ONLINE20 – Insights on Tariff Effects, Global Trade, and Industry Disruptors

What Is The Predicted Market Size Of The Cell Banking Outsourcing Industry By 2029?

The expansion of the cell banking outsourcing market has accelerated significantly in the past few years. It is projected to increase from $11.19 billion in 2024 to $12.86 billion in 2025, with a compound annual growth rate (CAGR) of 15.0%. The increasing cases of chronic illnesses, the growth in government-initiated programs, regulatory help and guidelines, alongside the growth in banking services establishments are all key contributors to the historic period expansion.

The market size of cell banking outsourcing is projected to experience a significant surge in the coming years. It is anticipated to expand to “$21.65 billion by 2029, with a compound annual growth rate (CAGR) of 13.9%. The expansion during the forecast period is due to various factors such as increased usage of cellular products, heightened demand for monoclonal antibodies, greater application of stem cell therapies, the increasing elderly population, and a rising reliance on cell-based treatments. Key trends for the forecast period consist of product innovations, technological progression, investment in research and development, and partnerships between biotech firms and dedicated cell banking services.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15754&type=smp

Which Key Factors Are Fueling Growth In The Cell Banking Outsourcing Market?

The increase in chronic disease prevalence is likely to fuel the expansion of the cell banking outsourcing market. Chronic diseases are protracted ailments that usually evolve incrementally and remain for a prolonged duration. The escalating incidence of such diseases is associated with an amalgamation of several aspects, encompassing changes in lifestyle, ageing demographic, and genetic predisposition. Cell banking outsourcing is paramount in expediting research and development initiatives to tackle chronic illnesses by offering access to proficiency, resources, and facilities that might be lacking in-house. For example, as stated by the Department of the Treasury, an Australia-based national treasury and financial department, in July 2023, nearly half (46.6%) of Australians irrespective of age had at least one chronic disease in 2020–21, and nearly one in five (18.6%) had more than one chronic ailment. Consequently, the mounting burden of chronic diseases is steering the growth of the cell banking outsourcing market.

Which Segmentation Factors Are Critical In The Cell Banking Outsourcing Market Analysis?

The cell banking outsourcing market covered in this report is segmented –

1) By Type: Master Cell Banking, Working Cell Banking, Viral Cell Banking

2) By Cell Type: Stem Cell Banking, Non-Stem Cell Banking

3) By Phase: Bank Storage, Bank Characterization And Testing, Bank Preparation

Subsegments:

1) By Master Cell Banking: Human Master Cell Bank, Animal Master Cell Bank

2) By Working Cell Banking: Human Working Cell Bank, Animal Working Cell Bank

3) By Viral Cell Banking: Virus Bank For Vaccine Production, Viral Vector Bank For Gene Therapy, Adenovirus Bank

What Are The Dominant Trends Currently Seen In The Cell Banking Outsourcing Market?

Prominent players in the cell banking outsourcing market are prioritizing the creation of cutting-edge solutions including single-cell potency characterization platforms for accurate and comprehensive analysis of an individual cell’s potency. The single-cell potency characterization platform represents an advanced technology or collection of methods aimed at evaluating the potency and functionality of single cells within a cell population. For instance, in January 2024, Cellply Srl, a biotech firm located in Italy, introduced VivaCyte – its premier product, and a comprehensive single-cell potency characterization platform combining potency analysis and immunophenotyping to expedite cell therapy R&D. The VivaCyte platform is fully automated, standalone, and capable of single-cell resolution, designed to cut down on development time, expenses, and risk by rapidly and fully characterizing the intricate functionality and mechanisms of potential cellular immunotherapies. The platform allows for quick testing of multiple cell therapy options from diverse processing choices against various target tumor cells, it offers consistent immune cell and single-cell functional characterization in much less time than traditional analytical tools require.

Who Are The Dominant Players In The Cell Banking Outsourcing Market Today?

Major companies operating in the cell banking outsourcing market are LabCorp Drug Development, SGS Life Sciences, Lonza Group Ltd., WuXi AppTec, Charles River Laboratories, Sigma-Aldrich Co. Ltd., Covance Inc., Global Stem Inc., LifeCell, Cryoviva India, Sartorius AG, Bio Reliance, CordLife, Reliance Life Sciences, Cryo-Cell International Inc., Toxikon Corp., Cleancells, Clean Biologics, Texcell, PX’Therapeutics SA, Goodwin Biotechnology Inc., Transcell Biolife Pvt Ltd., Perfectus Biomed Limited, BioStorage Technologies Inc.

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/cell-banking-outsourcing-global-market-report

Which Region Is Likely To Register The Fastest Growth In The Cell Banking Outsourcing Market?

North America was the largest region in the cell banking outsourcing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell banking outsourcing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=15754&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Outlook for the OTC Drug And Dietary Supplement Market Heading Into 2029?

In the recent past, there has been swift expansion in the cell banking outsourcing market size. Projections indicate an escalation from $11.19 billion in 2024 to $12.86 billion in 2025, reflecting a compound annual growth rate (CAGR) of 15.0%. This significant growth during the historical period can be linked to factors such as the heightened occurrence of chronic diseases, a surge in government-driven initiatives, regulatory backing and guidelines, and a rise in the formulation of banking services.

The market size for cell banking outsourcing is projected to experience a swift surge in the immediate future. Its accelerating growth is expected to hit “$21.65 billion by 2029, expanding at a compound annual growth rate (CAGR) of 13.9%. The market’s growth in the forecast period can be linked to factors such as the increased use of cell-based products, heightened demand for monoclonal antibodies, and an uptick in the acceptance of stem cell therapies. Other contributing factors include a growing aging population and an increasing reliance on cell-based therapies. Key trends that are expected to shape the landscape of the market forecast period include product innovation, advancements in technology, increased investment in R&D, and strategic partnerships between biotech entities and specialized cell banking services.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15754&type=smp

Which Factors Are Pushing The OTC Drug And Dietary Supplement Market Forward?

The OTC drug and dietary supplement market is anticipated to flourish due to an increase in pharma R&D spending. This investment pertains to the expenditure by a company on research, development, and improvement of its products. Higher spending could lead to more creative and productive design and formulation of OTC and dietary supplements. For example, Eurostat, a statistical office in Luxembourg under the European Union, reported in December 2023 that the R&D expenditure for the EU in 2022 amounted to €352 billion ($384.42 billion), a 6.34% increase from €331 billion ($361.48 billion) in the previous year. Hence, the growth in pharma R&D spending is propelling the OTC drug and dietary supplement market forward.

The cell banking outsourcing market covered in this report is segmented –

1) By Type: Master Cell Banking, Working Cell Banking, Viral Cell Banking

2) By Cell Type: Stem Cell Banking, Non-Stem Cell Banking

3) By Phase: Bank Storage, Bank Characterization And Testing, Bank Preparation

Subsegments:

1) By Master Cell Banking: Human Master Cell Bank, Animal Master Cell Bank

2) By Working Cell Banking: Human Working Cell Bank, Animal Working Cell Bank

3) By Viral Cell Banking: Virus Bank For Vaccine Production, Viral Vector Bank For Gene Therapy, Adenovirus Bank

What Future Market Trends Are Projected For The OTC Drug And Dietary Supplement Industry?

Significant players in the cell banking outsourcing market are concentrating on the creation of technologically superior solutions, like single-cell potency characterization platforms, to deliver accurate and comprehensive analyses of each cell’s potency. These platforms or methodology combinations are engineered to evaluate and quantify the proficiency and functional aptitudes of isolated cells within a populace of cells. For example, in January 2024, an Italian biotech firm, Cellply Srl, unveiled its main product, VivaCyte, which is an end-to-end single-cell potency characterization platform that combines potency assessment and immunophenotyping to streamline cell therapy research and development. VivaCyte is a self-contained, fully automated platform with single-cell precision, built to condense development durations, expenses, and hazards by rapidly and exhaustively characterizing the sophisticated functionality and working mechanism of prospective cellular immunotherapies. This platform expedites the examination of numerous cell therapy candidates from a range of process alternatives against multiple target cancer cells, ensuring consistent immune cell evaluation and individual cell functional profiling in a fraction of the timeframe required by existing analytical instruments.

Which Organizations Are Driving Progress In The OTC Drug And Dietary Supplement Industry?

Major companies operating in the cell banking outsourcing market are LabCorp Drug Development, SGS Life Sciences, Lonza Group Ltd., WuXi AppTec, Charles River Laboratories, Sigma-Aldrich Co. Ltd., Covance Inc., Global Stem Inc., LifeCell, Cryoviva India, Sartorius AG, Bio Reliance, CordLife, Reliance Life Sciences, Cryo-Cell International Inc., Toxikon Corp., Cleancells, Clean Biologics, Texcell, PX’Therapeutics SA, Goodwin Biotechnology Inc., Transcell Biolife Pvt Ltd., Perfectus Biomed Limited, BioStorage Technologies Inc.

https://www.thebusinessresearchcompany.com/report/cell-banking-outsourcing-global-market-report

Which Region Is Expected To Experience The Highest Growth In The OTC Drug And Dietary Supplement Industry?

North America was the largest region in the cell banking outsourcing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell banking outsourcing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=15754&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model